Claims Substantiation – An Integrated Clinical and Regulatory Approach
October 11, 2017
2 p.m. ET
Hosted by Xtalks
Product claims are integral to effective product positioning. With a strong, proven claim, companies can differentiate their brand while reinforcing the product’s health and nutritional benefits and performance. Successful claim substantiation also may enable companies to reposition existing products into new product categories and gain access to new markets. Being specific about the claimed effect, conditions of use, formulation and duration will make these claims easier to prove, especially when following an integrated and well-designed regulatory and clinical approach.
It is also necessary to recognize the risks associated with claim substantiation. Proper clinical trial design is essential for successfully executing a claims substantiation trial.
What You’ll Learn From This Webinar:
- Ensuring successful product claims
- Developing a well-designed and integrated regulatory and clinical research approach
- Recognizing critical risks
- Understanding regulations and the evidence required based on geographic location
- Probiotic research nuances in trial design
Josh Baisley, B.Sc., Director of Clinical Trials
Joshua Baisley joined Nutrasource in 2013, bringing over 12 years of quality assurance, clinical, preclinical and regulatory natural health product experience and an additional four years of antibody/biologics development experience. Josh has been an active member in the probiotic community as a member of the International Probiotics Association (IPA) Board of Directors, blogging for the IPA, and presenting at the probiotic workshop as well as at the Probiotics Resource Center at SupplySide West in 2016 and 2017 and Vitafoods Europe in 2017.
Having depth in both regulatory filings and project management of clinical trials provides Josh with an understanding of regulatory body thinking and has led to his respected relationship with Health Canada. From 2011-2014, Josh participated on a Health Canada expert working group as a member representing the dietary supplement industry to work toward harmonization of safety reporting for supplements, drugs and biologics. Josh’s regulatory filings throughout his career account for over 10 percent of all applications received by Health Canada’s Natural and Non-prescription Health Products Directorate for clinical research trials. Josh has a Hons. B.Sc. from the University of Guelph, specializing in microbiology and a certificate in regulatory affairs.
Will Rowe, B.A., President, CEO and Co-Founder
William Rowe co-founded Nutrasource Diagnostics Inc. with Dr. Bruce J. Holub in May 2002 with the intent to market a novel diagnostic test called the Omega Score. Since that time, Nutrasource has grown to become a world leader in servicing the global health product’s industry in clinical, regulatory, analytical and bioanalytical services as well as Omega-3 and GMO product certification programs. Throughout his tenure as president and CEO, William has been nominated for The Ernst and Young Entrepreneur of Year Award twice and has led Nutrasource to place on the PROFIT 500 list of Canada’s Fastest Growing Companies over the last five years.
Rachel Rebry, M.Sc., Associate Director, Regulatory Affairs
Rachel Rebry has extensive working knowledge on the regulatory frameworks for both Canada and the United States. Since joining the Nutrasource team in 2009, Rachel has acted as the project manager on product and site license applications to Health Canada’s Natural and Non-prescription Health Products Directorate, involving ingredient safety and efficacy assessment, claim development, quality review, and compliance with Good Manufacturing Practices. She also has experience in working with new food health claim applications, GRAS assessments, supplemented foods, cosmetics, infant formula, low-risk veterinary natural health products, food additives and medical foods.
Throughout her career, Rachel has also been the lead on jurisdictional investigations to determine the pathway of optimal positioning in the marketplace for new consumer health products. In addition, she has excelled in open collaboration with regulatory agencies and over 75 sponsors determining need, requirement and comprehension of the best possible regulatory pathway for success.
Back to News